Fiber GI
Natural health product licensed in Canada
- Other names
- FiberGI
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80128355
- Status
- Active licence
- Licence date
- 30 November 2023
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pediococcus acidilactici Source : KABP-021 | 1 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : Pediococcus acidilactici - Whole Cell | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Ascorbate de sodium, Dextrose, Trehalose, Citrate de sodium, D-Mannitol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 8 years ; maximum: 11 years | 1 Portions | 1 Tous les jours |
| Adultes | minimum: 19 years | 1 Portions | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
| Enfants et Adolescents | minimum: 12 years ; maximum: 18 years | 1 Portions | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps to improves gut-related stress/discomfort from IBS in 6 weeks in adults. Help improves quality of life in adults with diarrhea-predominant irritable bowel syndrome. Helps improve quality of life by relieving IBS symptoms in adults. Helps reduce symptoms of lactose intolerance such as abdominal pain and flatulence in adults. Helps relieve symptoms of irritable bowel syndrome (IBS) in adults. Helps relieve the symptoms of irritable bowel syndrome (IBS) (abdominal pain, bloating, distension) in adults. Helps to manage IBS symptoms in adults that impacts their quality of life. Helps improve quality of life in IBS patients by supporting gut health and improving gut comfort in adults Helps improve IBS-related quality of life in adults with IBS and diarrhea. Source of fiber for the maintenance of healthy gastrointestinal functions. Helps to improve intestinal regularity including constipation and/or diarrhea. Helps to improve bowel regularity in people with Irritable Bowel Syndrome (IBS). Helps to relieve constipation and mild gastrointestinal discomfort in people with Irritable Bowel Syndrome (IBS). Helps to reduce the frequency of bowel irregularity and minor abdominal discomfort in people with Irritable Bowel Syndrome (IBS). Helps to relieve minor gastrointestinal symptoms associated with Irritable Bowel Syndrome (IBS) including flatulence, bloating, dyspepsia and altered bowel habits. Helps to relieve bowel irregularity, bloating and other minor gastrointestinal symptoms in people with Irritable Bowel Syndrome (IBS). Helps to improve intestinal regularity in children. Provides a gentle relief of constipation. Provides a gentle relief of constipation in children. Helps modulate stool conditions (from either loose or hard) to normal conditions. Helps reduce the need for laxative use. Helps reduce incidents of diarrhea. Helps reduce glycemic response and glycemic index when taken with food.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80128355
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.